BioCatalystWatch
COLLWorkspace / COLL / OverviewCompany library
COLLEGIUM PHARMACEUTICAL, INC logo

COLLEGIUM PHARMACEUTICAL, INC

COLLEGIUM PHARMACEUTICAL, INC (COLL)

Website

Featured programme · AZSTARYS

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Other pipelines

Approved / commercial

Nucynta

PreINDP1P2P3FilingApproved
Belbuca

Approved

PreINDP1P2P3FilingApproved
Xtampza ER

Approved

PreINDP1P2P3FilingApproved
Jornay PM®

Approved

PreINDP1P2P3FilingApproved
AZSTARYS

Approved

PreINDP1P2P3FilingApproved
Nucynta® IR

Approved

PreINDP1P2P3FilingApproved
Nucynta® ER

Approved

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

COLL PR & News

PR & News

COLL SEC archive